Language selection

Search

Patent 2247016 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2247016
(54) English Title: PURIFICATION OF THROMBIN-LIKE PROTEASES FROM SNAKE VENOMS
(54) French Title: PURIFICATION DE PROTEASES DE TYPE THROMBINE PROVENANT DE VENINS DE SERPENT
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
(51) International Patent Classification (IPC):
  • C12N 9/64 (2006.01)
  • A61K 35/583 (2015.01)
  • A61K 38/48 (2006.01)
  • C07K 1/16 (2006.01)
(72) Inventors :
  • SCHWARZ, MARGARETE (Germany)
  • ZAHN, WOLFGANG (Germany)
(73) Owners :
  • NORDMARK HOLDING GMBH
(71) Applicants :
  • NORDMARK HOLDING GMBH (Germany)
(74) Agent: ROBIC AGENCE PI S.E.C./ROBIC IP AGENCY LP
(74) Associate agent:
(45) Issued: 2006-10-24
(86) PCT Filing Date: 1997-02-18
(87) Open to Public Inspection: 1997-09-04
Examination requested: 2002-01-09
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/EP1997/000755
(87) International Publication Number: WO 1997032015
(85) National Entry: 1998-08-20

(30) Application Priority Data:
Application No. Country/Territory Date
19607210.7 (Germany) 1996-02-26

Abstracts

English Abstract


Described is a method of purifying thrombin-like protease enzymes from snake
venom, the method consisting of freeing the enzymes
of impurities in three chromatographic stages.


French Abstract

L'invention concerne un procédé pour purifier des protéases analogues à la thrombine issues du venin de serpent, consistant à libérer les protéases des impuretés en trois étapes chromatographiques.

Claims

Note: Claims are shown in the official language in which they were submitted.


7
CLAIMS
1. A method of purifying a thrombin-like protease from a snake venom,
which method comprises:
a) obtaining a solution comprising the protease;
b) loading the protease solution onto an affinity chromatography matrix or an
anion exchange resin;
c) eluting the protease in an eluate solution from the affinity chromatography
matrix or anion exchange resin;
d) loading the eluate solution from step c) onto a matrix of glass beads; said
glass beads having a pore diameter of from 25 to 35 nm and a particle size of
from 30 to 60 µm; said eluate being applied to the matrix of glass beads in
a
basic solution at a pH value of from 7.5 to 9.0 whereby the glass beads adsorb
the thrombin-like protease from snake venom;
e) eluting the protease in an eluate solution from the matrix of glass beads;
f) loading the eluate solution from step e) onto a size exclusion gel matrix
or
onto a matrix of glass beads; said glass beads having a pore diameter of from
90 to 110 nm and a particle size of from 30 to 60 µm; said eluate being
applied
to the matrix of glass beads in an acidic solution; and
g) eluting and recovering the purified protease.
2. The method of claim 1, wherein the purification in step f) is carried out
using a size exclusion gel matrix.
3. The method of claim 1 or 2, wherein the eluate solution is loaded onto a
matrix of glass beads in step f).
4. The method of any one of claims 1 to 3, in which the snake venom is from
a snake of the genus Agkistrodon.
5. The method of claim 4, in which the snake venom is from Agkistrodon
rhodostoma.

8
6. The method of claim 1, wherein the purified product is ancrod.

Description

Note: Descriptions are shown in the official language in which they were submitted.


CA 02247016 2005-O1-27
1
PURIFICATION OF THROMBIN-LIKE PROTEASES FROM SNAKE VENOMS
The present invention relates to a process i:or purifying throm-
bin-like proteases from snake venoms.
Examples of sut:h proteases are batroxobin, c:rotalase and, in par-
ticular, ancrod. The latter is an anticoagulant which is isolated
from the venom of the snake Agkistrodon rhodostoma (Merck Index
1989, No. 664). A mult'iplicitx of methods for its preparation
from snake venom have already been described (GB Patent
1,:094,301, GB Patent 1,177,506, GB Patent 1,,293,793, US Patent
3,743,722, US Patent 3,879,369, German Offenlegungsschrift
2,428,955, German Offenlegungsschrift 2,734,427). These processes
are essentially based on chromatographic steps and yield the an-
crod in varying yield and purity.
The preparation of, highly pure ancrod from anake venom has been
unsuccessful until now. A mixture of enzyme's with ancrod as the
main component was always isolated which, depending on the prepa-
ration, was contaminated with more or less foreign proteins.
A way has.now been found to prepare thrombin-like proteases from
snake venoms in highly pure form.
The invention relates tea a process for, purifying thrombin-'like
proteases.from snake venoms, which consists in
(1) subjecting.a protease crude product to a prepurification by
affinity chromatography or chromatography on a basic ion ex-
changer,. '
(2) subjecting the fraction'containing the thrombin-like enzymes
thus obtained to chromatography on a weak cation exchanger or
separating it in the basic range by ad:~orption on glass and
(3) subjecting the main component from step 2 to gel chroinatogra-
phy or purifying this component in the acidic range by chro-
matography.on glass;

CA 02247016 2005-O1-27
2
where, however, at least one of steps (2) and (3) comprises a separation by
adsorption or chromatography on glass.
More specifically, the invention as claimed relates t:o a process wherein the
above mentioned steps (1 ) to (3) are detailed as follows:
a) obtaining a solution comprising the protease;
b) loading the protease solution onto an affinity chromatography matrix or an
anion exchange resin;
c) eluting the protease in an eluate solution from the affinity chromatography
matrix or anion exchange resin;
d) loading the eluate solution from step c) onto a matrix of glass beads; said
glass beads having a pore diameter of from 25 to 35 nm and a particle size of
from 30 to 60 arm; said eluate being applied to the matrix of glass beads in a
basic solution at a pH value of from 7.5 to 9.0 whereby the glass beads adsorb
the thrombin-like protease from snake venom;
e) eluting the protease in an eluate solution from the matrix of glass beads;
f) loading the eluate solution from step e) onto a size exclusion gel matrix
or
onto a matrix of glass beads; said glass beads having a pore diameter of from
90 to 110 nm and a particle size of from 30 to 60 arm; said eluate being
applied
to the matrix of glass beads in an acidic solution; and
g) eluting and recovering the purified protease.
The invention furthermore relates to thrombin-like proteases from snake venoms
in a purity of from 95 to 100%.
It is recommended for step (2) to carry out the purification by adsorption on
glass and step {3) with the aid of gel chromatography.
In a particularly preferred embodiment of the invention, purification both in
step
(2) and in step (3) is carried out by adsorption or chrornatography on glass.

CA 02247016 2005-O1-27
3
Agmatine-, a~ginine- or heparin-Sepharose is particularly suita-
ble for the prepurification by affinity chromatography.
Basic ion exchangers suitable for the prepurification are parti-
cularly DEAF-cellulose and DEAF-Sepharose'~
Buffers which may be mentioned for ion exchange chromatography
are, in particular, tris-phosphate and sodium phosphate buffers:
Ion exchange chromatography is carried out at a pH of 5-9, prefe-
rably of 6-8.5.
During the prepurification, approximately 7()-80~ of foreign pro-
teins and other constituents are removed from the crude enzyme.
If the second step of the purification is carried out using a.ca-
tion exchanger, those suitable are the follbwing weakly acidic .
exchangersa CM-SEPHAROSE* pH 5-9, and AMBERLITE CG50* pH 5-9.
Chromatography on glass means that ancrod and related thrombin-
like enzymes as well as strongly basic proteases are bound to the
glass matrix at pHs of 7.5-9.0, preferably 8.0-8.5. About 60 ~ of
especially acidic foreign proteins are washed from the column in
unbound form with the equilibration buffer (preferably tris-phos-
phate or sodium phosphate buffer). ancrod is eluted from the
glass fractionally in over 90~ purity by increasing the ionic
strength of the buffer to 0.3-1.0 M by addition of sodium chlori-
de.
In the second purification step, the enzyme is concentrated to
approximately 90 0.
For gel chromatography as a purification step (3), suitable gels, in
particular,
are: SEPHACRYL S-100HR*, SUPERDEX*, SEPHADEX*, ULTRO-GEL* and
SUPEROSE*.
If chromatography on glass is selected for this purification step (3), in the
acidic
pH range from 4-6 basic foreign proteins are adsorbe(i on the glass surface
from
the ancrod solution, while ancrod can be eluted from the column directly in
the
* trademarks

CA 02247016 2005-O1-27
4
equilibration buffer in far aver 95% purity. The desired ionic strength of the
buffer
can be regulated by addition of a salt such as sodium r>hloride.
The novel process is very particularly suitable for the prepara-
tion of ancrod in pure form, which according to this purification
process is obtained in a purity of. clearly over 954.
Example 1
a. Prepurification
3 g of dried venom of the Malayan pit viper were dissolved in
50 ml of tris(hydroxymethyl)aminomethane(TRIS)-phosphate buffer
pH 8.5, insoluble cell constituents of the venom were centrifuged
off and the clear, yellow solution was applied to a chromatogra-.
phy column which had a diameter of 1.6 cm and was packed up to a
height of 30 cm with DEAE-SEPHAROSE*FF (Pharmacies). The thrombin-
like enzymes of the venom and the proteins having acidic charac-
ter were bound to the matrix. Chromatography was carried out at a
flow rite of 150 - 200 ml/h. By washing the column at room tempe-
rature with about 300 m1 of equilibration buffer (10 mM TRIS-
phosphate buffer pH 8.5) until the A28omm [sic] value of the eluate
had fallen below 0.5 and further washing with 400 ml of 35 mM
TRIS-phosphate buffer pH 6.0 until the Az$o~" [sic] value of the
eluate was < 0.4, about 70 - 80 ~ of the foreign proteins (based
on the optical density of the starting solution at 280 nm) were
eluted. The main fraction containing ancrocl was eluted in 85 %
yield in 150 - 200 ml of 150 mM TRIS-phosphate buffer pH 6Ø
b. Main purification
The eluate which contained the ancrod was e:oncentrated to 20 ml
by means of ultrafiltration on a membrane having a nominal sepa-
ration limit of 10000 Daltons and rebuffered using a 100 mM TRIS-
phosphate buffer pH 8Ø This solution was applied to a column
which had a diameter of 1.6 cm and was packed up to a height of
l5 cm with BIORAN-CPG'~glass (Schott, pore diameter: 25 - 35 nm,
particle size: 30. - 60 Eun). By washing the column at room tempera-
ture with 300 ml.of the 100 mM TRIS-phosphate buffer pH 8.0 and
at a flow rate of 250 ml per hour, about 60 °s of foreign proteins
(based on the optical density of the material applied at 280 nm)
'~ trademarks

CA 02247016 2005-O1-27
4a
were eluted from the column.
For elution, a 0.5 M sod~,um chloride solution which was buffered
to a pH of 8.0 using 100~mM TRIS-phosphate was employed. The
eluate was automatical~.y collected in about 10 ml fractions. The
thrombin-like enzymes were eluted in one peak with a subsequent
tailing range. In order to obtain the main .component (corresponds
to ancrod) in a form which contained at most 5 % of thrombin-like
secondary components, in the transition from the main peak to the
tailing range individual fractions were investigated by means of
reverse-phase HPLC both for their specific fibrinogenase activity
and for their composition. Only fractions which had a specific
activity of greater than 1700 U/OD28ox"" and which contained less
than 10 % of secondary components in HPLC were combined with the
main peak (about 80 mi). The main component was obtained from the
BIORAN column in a purity of 96 % and a yield of ?2 %.
c. Fine purification
The eluate containing the main component ancrod was concentrated
to 2 ml by ultrafiltration on a YM 10 memMrane (Amicon) and the
concentrate obtained was applied to a column which had a diameter.
of 1.6 cm and was packed up to a height of 85 cm with SEPHARYL~'
S-100 HR. The column had been equilibrated beforehand using a
buffer of 100 mM sodium chloride and 100 mM sodium phosphate,
which had a pH of 6.9. Residual proteases and TRIS were separated
from ancrod by means of this gel chromatography. The yield in
this step was about 90 %.
Example 2
a. Prepurification
2.1 g of dried venom of the Malayan pit viper were dissolved in
50 ml of 35 mM TRIS-phosphate buffer pH 8.5, insoluble cell con-
stituents of the venom were centrifuged off and the clear, yellow
solution was applied to a chromatography column which had a dia-
meter of 1.6 cm, was.packed up to a height of 30 cm with DEAF-SE-
PHAROSE-FF~(Pharmacia) and was equilibrated with the buffer men-
tioned above. By washing the column at room temperature with 600
ml of equilibration buffer until the A28o [sic] value of the
* trademarks

0480/01161 CA 02247016 1998-os-ZO
eluate was < 0.2, approximately 70 % of the foreign proteins
(based on the optical density of the starting solution at 280 nm)
were eluted. The main fraction was eluted in 90 - 100% yield
using 200 - 250 ml of 150 mM TRIS-phosphate buffer pH 6Ø
5
b. Main purification
The eluate was concentrated to 20 ml as in Example 1 and
rebuffered using a 50 mM Na phosphate buffer pH 8.5. This
solution was applied to the BIORAN-CPG glass column (diameter:
1.6 cm, height: 15 cm, pore diameter:~25 - 35 nm, particle size:
30 - 60 Nm). By washing the column at room temperature with 300 ml
of the 50 mM Na phosphate buffer pH 8.5 and at a flow rate of 250
ml per hour, about 60 % of foreign proteins (based on the optical
density of the material applied at 280 nm) were eluted from the
column.
For elution of the thrombin-like enzymes, a 1 M sodium chloride
solution which had been buffered to a pH of 8.0 using 50 mM Na-
phosphate was employed. Using 150 ml of buffer, about 80 % of the
units of enzyme applied were eluted.
c. Fine purification
The eluate was concentrated to 20 ml as above and rebuffered
using a 50 mM Na phosphate buffer which had a pH of 5Ø This so-
lution was applied to a column which also had a diameter of
1~6 cm and was packed up to a height of 15 cm with BIORAN-CPG
glass which, however, had a pore diameter of 90 - 110 nm and a
particle size of 30 - 60 ~.m. At pH 5.0, only basic proteins and
the secondary components were bound to the BIORAN glass, while
the main component ancrod was eluted from the column using the
equilibration buffer in a purity of approximately 100 % and in
about 80 - 90% yield (based on the units applied).
Example 3
a, b. Pre- and main purification
2.1 g of dried venom of the Malayan pit viper were prefractiona-
ted on DEAF-SEPHAROSE analogously to Example 2, and the eluate
was concentrated to 20 ml analogously to Example 1 and rebuffered
using a 40 mM TRIS-phosphate buffer pH 6.2. This solution was ap-
plied to a chromatography column which had a diameter of 1.6 cm,
[lacuna] packed up to a height of 20 cm with CM-SEPHAROSE-FF

0480/01161 CA 02247016 1998-os-Zo
6
(Pharmacia) and was equilibrated with the abovementioned buffer.
By washing the column at room temperature with 300 ml of the
equilibration buffer and at a flow rate of 250 ml/h, about 60 %
of foreign proteins (based on the optical density of the material
applied at 280 nm) were eluted from the column.
For elution of the thrombin-like enzymes, analogously to Example
2 a 1 M sodium chloride solution which was buffered to a pH of
8.0 using 50 mM Na phosphate was employed. Using 150 ml of buf-
fer, about 80 % of the units of thrombin-like enzymes applied
were eluted.
c. Fine purification
The fine purification of ancrod was carried out analogously to
Example 2 on BIORAN-CPG glass (pore diameter about 100 nm; parti-
cle size 30 - 60 Eun) using a 50 mM phosphate buffer pH 5Ø, Ancrod
was eluted from the column in over 95% purity and in about 85%
yield (based on the units applied).
30
40

Representative Drawing

Sorry, the representative drawing for patent document number 2247016 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: Expired (new Act pat) 2017-02-18
Inactive: IPC deactivated 2015-03-14
Inactive: IPC from PCS 2015-01-17
Inactive: IPC expired 2015-01-01
Inactive: IPC assigned 2014-10-24
Inactive: IPC assigned 2014-10-24
Inactive: IPC assigned 2014-10-24
Inactive: Late MF processed 2013-03-04
Letter Sent 2013-02-18
Letter Sent 2013-01-14
Inactive: Single transfer 2012-12-12
Inactive: Correspondence - MF 2010-08-10
Grant by Issuance 2006-10-24
Inactive: Cover page published 2006-10-23
Pre-grant 2006-08-07
Inactive: Final fee received 2006-08-07
Notice of Allowance is Issued 2006-02-21
Notice of Allowance is Issued 2006-02-21
Letter Sent 2006-02-21
Inactive: Approved for allowance (AFA) 2005-10-31
Amendment Received - Voluntary Amendment 2005-01-27
Inactive: S.29 Rules - Examiner requisition 2004-08-26
Inactive: S.30(2) Rules - Examiner requisition 2004-08-26
Letter Sent 2003-03-25
Letter Sent 2003-03-25
Letter Sent 2003-03-25
Letter Sent 2002-02-07
All Requirements for Examination Determined Compliant 2002-01-09
Request for Examination Requirements Determined Compliant 2002-01-09
Request for Examination Received 2002-01-09
Inactive: IPC assigned 1998-11-18
Classification Modified 1998-11-18
Inactive: First IPC assigned 1998-11-18
Inactive: Notice - National entry - No RFE 1998-10-27
Application Received - PCT 1998-10-23
Application Published (Open to Public Inspection) 1997-09-04

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 2005-12-21

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
NORDMARK HOLDING GMBH
Past Owners on Record
MARGARETE SCHWARZ
WOLFGANG ZAHN
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Abstract 1998-08-20 1 48
Description 1998-08-20 6 278
Claims 1998-08-20 1 27
Cover Page 1998-11-20 1 24
Description 2005-01-27 7 356
Claims 2005-01-27 2 49
Cover Page 2006-09-26 1 25
Reminder of maintenance fee due 1998-10-26 1 110
Notice of National Entry 1998-10-27 1 192
Courtesy - Certificate of registration (related document(s)) 1998-10-26 1 114
Reminder - Request for Examination 2001-10-22 1 118
Acknowledgement of Request for Examination 2002-02-07 1 178
Commissioner's Notice - Application Found Allowable 2006-02-21 1 162
Courtesy - Certificate of registration (related document(s)) 2013-01-14 1 101
Late Payment Acknowledgement 2013-03-11 1 164
Maintenance Fee Notice 2013-03-11 1 171
Late Payment Acknowledgement 2013-03-11 1 164
PCT 1998-08-20 18 646
Correspondence 2006-08-07 1 31
Correspondence 2010-08-10 1 46